nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—adrenal gland cancer	0.935	1	CbGaD
Flupentixol—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000342	0.00532	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00033	0.00513	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000325	0.00505	CbGpPWpGaD
Flupentixol—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.000317	0.00492	CbGpPWpGaD
Flupentixol—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.000312	0.00485	CbGpPWpGaD
Flupentixol—DDC—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000308	0.00479	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000307	0.00477	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000302	0.00469	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000289	0.0045	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000283	0.0044	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000282	0.00438	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000279	0.00434	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000275	0.00427	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000274	0.00425	CbGpPWpGaD
Flupentixol—DRD1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.000271	0.00421	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000269	0.00418	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000269	0.00418	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000266	0.00413	CbGpPWpGaD
Flupentixol—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000262	0.00406	CbGpPWpGaD
Flupentixol—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000257	0.00399	CbGpPWpGaD
Flupentixol—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000253	0.00393	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000251	0.0039	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000249	0.00387	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000245	0.00381	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000244	0.00379	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000241	0.00375	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00024	0.00373	CbGpPWpGaD
Flupentixol—DDC—Metabolism—RRM1—adrenal gland cancer	0.00023	0.00358	CbGpPWpGaD
Flupentixol—DDC—Metabolism—SDHD—adrenal gland cancer	0.00023	0.00358	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000213	0.00331	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000209	0.00325	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000208	0.00324	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000205	0.00319	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000201	0.00312	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000198	0.00307	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000196	0.00305	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000193	0.00301	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00019	0.00295	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.000187	0.0029	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000187	0.0029	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000186	0.00288	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.000183	0.00284	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000182	0.00283	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000182	0.00283	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000179	0.00279	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000178	0.00277	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000176	0.00273	CbGpPWpGaD
Flupentixol—DDC—Metabolism—MED12—adrenal gland cancer	0.000172	0.00267	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000171	0.00265	CbGpPWpGaD
Flupentixol—DDC—Circadian rythm related genes—TP53—adrenal gland cancer	0.000167	0.0026	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000159	0.00247	CbGpPWpGaD
Flupentixol—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00015	0.00232	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000146	0.00227	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000145	0.00225	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000143	0.00222	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000142	0.00221	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000133	0.00206	CbGpPWpGaD
Flupentixol—Fluphenazine—ABCB1—adrenal gland cancer	0.00013	0.388	CrCbGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000129	0.00201	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000129	0.002	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PRKACA—adrenal gland cancer	0.000125	0.00195	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000125	0.00194	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000123	0.00191	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00012	0.00187	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00012	0.00186	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000118	0.00184	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000118	0.00183	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000116	0.0018	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00011	0.00171	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000109	0.0017	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000109	0.00169	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000108	0.00168	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000108	0.00167	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000107	0.00167	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000107	0.00167	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000107	0.00166	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000106	0.00165	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000106	0.00165	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000105	0.00164	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000105	0.00164	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000105	0.00163	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000105	0.00163	CbGpPWpGaD
Flupentixol—Trifluoperazine—ABCB1—adrenal gland cancer	0.000104	0.31	CrCbGaD
Flupentixol—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000104	0.00161	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000103	0.0016	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GNAS—adrenal gland cancer	0.000101	0.00158	CbGpPWpGaD
Flupentixol—Quetiapine—ABCB1—adrenal gland cancer	0.000101	0.301	CrCbGaD
Flupentixol—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0001	0.00156	CbGpPWpGaD
Flupentixol—DDC—Metabolism—ABCB1—adrenal gland cancer	9.96e-05	0.00155	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.85e-05	0.00153	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—POMC—adrenal gland cancer	9.84e-05	0.00153	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.8e-05	0.00152	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	9.78e-05	0.00152	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.76e-05	0.00152	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	9.74e-05	0.00151	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.73e-05	0.00151	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.65e-05	0.0015	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.6e-05	0.00149	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	9.58e-05	0.00149	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.55e-05	0.00148	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	9.53e-05	0.00148	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	9.41e-05	0.00146	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.4e-05	0.00146	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	9.38e-05	0.00146	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	9.26e-05	0.00144	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	9.25e-05	0.00144	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	9.21e-05	0.00143	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	9.07e-05	0.00141	CbGpPWpGaD
Flupentixol—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	8.74e-05	0.00136	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.72e-05	0.00135	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	8.64e-05	0.00134	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	8.55e-05	0.00133	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	8.26e-05	0.00128	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	7.85e-05	0.00122	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	7.82e-05	0.00121	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	7.62e-05	0.00118	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	7.5e-05	0.00117	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	7.43e-05	0.00115	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	7.33e-05	0.00114	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	7.31e-05	0.00114	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	7.29e-05	0.00113	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	7.27e-05	0.00113	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	7.18e-05	0.00112	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	7.16e-05	0.00111	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	7.16e-05	0.00111	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	7.15e-05	0.00111	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.99e-05	0.00109	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	6.87e-05	0.00107	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.84e-05	0.00106	CbGpPWpGaD
Flupentixol—DDC—Metabolism—POMC—adrenal gland cancer	6.83e-05	0.00106	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	6.73e-05	0.00105	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	6.6e-05	0.00103	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	6.53e-05	0.00101	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.52e-05	0.00101	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	6.46e-05	0.001	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	6.45e-05	0.001	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.42e-05	0.000998	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.4e-05	0.000994	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	6.39e-05	0.000992	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	6.35e-05	0.000986	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	6.31e-05	0.000981	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.29e-05	0.000977	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	6.24e-05	0.000969	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	6.22e-05	0.000966	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.14e-05	0.000953	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	6.1e-05	0.000948	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.01e-05	0.000933	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	5.93e-05	0.000921	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	5.9e-05	0.000917	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	5.83e-05	0.000906	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	5.81e-05	0.000902	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	5.8e-05	0.000901	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	5.78e-05	0.000897	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	5.75e-05	0.000893	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	5.71e-05	0.000887	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	5.69e-05	0.000883	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	5.66e-05	0.00088	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	5.66e-05	0.000879	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	5.63e-05	0.000874	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.62e-05	0.000873	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.62e-05	0.000873	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	5.57e-05	0.000866	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	5.56e-05	0.000864	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	5.54e-05	0.000861	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	5.54e-05	0.000861	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	5.47e-05	0.000849	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	5.46e-05	0.000848	CbGpPWpGaD
Flupentixol—DDC—Metabolism—PTGS2—adrenal gland cancer	5.45e-05	0.000847	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	5.41e-05	0.00084	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	5.32e-05	0.000827	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	5.29e-05	0.000822	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.29e-05	0.000821	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	5.21e-05	0.000809	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.07e-05	0.000788	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	5.05e-05	0.000785	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	4.64e-05	0.00072	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	4.47e-05	0.000694	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	4.43e-05	0.000688	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	4.32e-05	0.000671	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.26e-05	0.000661	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.2e-05	0.000652	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—MED12—adrenal gland cancer	4.19e-05	0.000651	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	4.13e-05	0.000642	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.13e-05	0.000641	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	4.11e-05	0.000638	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	4.06e-05	0.000631	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.05e-05	0.000628	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	4.04e-05	0.000628	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	3.98e-05	0.000618	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.81e-05	0.000592	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.75e-05	0.000583	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	3.73e-05	0.00058	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TERT—adrenal gland cancer	3.72e-05	0.000578	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	3.67e-05	0.000571	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.5e-05	0.000544	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.44e-05	0.000535	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.43e-05	0.000532	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.37e-05	0.000524	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3.37e-05	0.000524	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.35e-05	0.00052	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.32e-05	0.000516	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.3e-05	0.000513	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.29e-05	0.000511	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.27e-05	0.000509	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.26e-05	0.000507	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	3.25e-05	0.000505	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—BAD—adrenal gland cancer	3.24e-05	0.000503	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	3.22e-05	0.000501	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.21e-05	0.000499	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	3.19e-05	0.000496	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.14e-05	0.000488	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.06e-05	0.000475	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—POMC—adrenal gland cancer	2.98e-05	0.000463	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	2.95e-05	0.000458	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	2.86e-05	0.000444	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.81e-05	0.000436	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.76e-05	0.000429	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.75e-05	0.000427	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.71e-05	0.00042	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.48e-05	0.000385	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.44e-05	0.00038	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.4e-05	0.000373	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.39e-05	0.000371	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.35e-05	0.000366	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.25e-05	0.00035	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.22e-05	0.000346	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.22e-05	0.000344	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.2e-05	0.000342	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.19e-05	0.00034	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.18e-05	0.000338	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	2.17e-05	0.000337	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.16e-05	0.000335	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	2.14e-05	0.000333	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.13e-05	0.000331	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	2.12e-05	0.00033	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.11e-05	0.000328	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.08e-05	0.000323	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	1.69e-05	0.000262	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—POMC—adrenal gland cancer	1.67e-05	0.000259	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.61e-05	0.00025	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.58e-05	0.000246	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.57e-05	0.000244	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.55e-05	0.000241	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—adrenal gland cancer	1.42e-05	0.00022	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.33e-05	0.000207	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	0.000198	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.25e-05	0.000195	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.25e-05	0.000194	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.23e-05	0.000191	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.07e-05	0.000166	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	1.05e-05	0.000163	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	1.05e-05	0.000163	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	1.03e-05	0.00016	CbGpPWpGaD
